United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2016_register executive 2018-02-07 article Notices D09002ee1c7f658a8 D09002ee1c7f65914 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a worldwide exclusive license to practice the inventions embodied in: HHS Ref. No. E-135-2015/0, U.S. Provisional Patent Application No. 62/ 155,085, filed April 30, 2015, entitled "Boron Mimics Of Amino Acids And Uses Thereof," to Beijing Lanyears Communication Technology, Ltd., a company formed under the laws of the People's Republic of China and having its principle place of business in Beijing, China. The contemplated exclusive license may be limited to boron neutron capture therapy for skin cancer. 81 FR 19984 https://www.govinfo.gov/app/details/FR-2016-04-06/2016-07864 2016-07864 fr06ap16-62 4140-01-P https://www.govinfo.gov/app/details/FR-2016-04-06/2016-07864 https://www.govinfo.gov/content/pkg/FR-2016-04-06/html/2016-07864.htm https://www.govinfo.gov/content/pkg/FR-2016-04-06/pdf/2016-07864.pdf 2 p. 19984 19985 81 FR 19984 Prospective Grant of an Exclusive Patent License for Commercialization: Boron Neutron Capture Therapy for Skin Cancer; Federal Register Vol. 81, Issue NOTICE 2016-07864 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2016-04-21 4140-01-P 2016-07864 Notice.

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a worldwide exclusive license to practice the inventions embodied in: HHS Ref. No. E-135-2015/0, U.S. Provisional Patent Application No. 62/ 155,085, filed April 30, 2015, entitled "Boron Mimics Of Amino Acids And Uses Thereof," to Beijing Lanyears Communication Technology, Ltd., a company formed under the laws of the People's Republic of China and having its principle place of business in Beijing, China. The contemplated exclusive license may be limited to boron neutron capture therapy for skin cancer.

Only written comments and/or applications for a license that are received by NIH at the address indicated below on or before April 21, 2016 will be considered. Prospective Grant of an Exclusive Patent License for Commercialization: Boron Neutron Capture Therapy for Skin Cancer , shmilovm@mail.nih.gov Vol. 81, no. 66 Office of the Federal Register, National Archives and Records Administration 2016-04-06 continuing daily deposited born digital 371 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2016-04-06 P0b002ee19859467c 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr06ap16 https://www.govinfo.gov/app/details/FR-2016-04-06 https://www.govinfo.gov/content/pkg/FR-2016-04-06/pdf/FR-2016-04-06.pdf https://www.govinfo.gov/content/pkg/FR-2016-04-06/xml/FR-2016-04-06.xml fdlp 19857 20218 DGPO 2018-02-07 2024-06-02 FR-2016-04-06 machine generated eng FR FR-2016-04-06 81 66